Livelsberger Financial Advisory’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-175
Closed -$48.8K 11
2025
Q2
$48.8K Buy
+175
New +$49.6K 0.94% 26
2024
Q4
Sell
-175
Closed -$56.3K 11
2024
Q3
$56.3K Buy
+175
New +$57.2K 1.18% 24
2024
Q1
Sell
-175
Closed -$50.3K 22
2023
Q4
$50.3K Buy
+175
New +$47.7K 0.05% 156

Other funds holding AMGN

Livelsberger Financial Advisory's AMGN Position: Q3 2025 in Review

Livelsberger Financial Advisory sold out of Amgen (AMGN) in Q3 2025, closing a stake of 175 shares — an estimated $48.8K sold.

Livelsberger Financial Advisory first reported a position in AMGN in Q4 2023 and held it in 3 quarters. The position peaked at $56.3K in Q3 2024. 2,823 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

  • Livelsberger Financial Advisory reported no remaining Amgen position as of Q3 2025 after selling out during the quarter.
  • Livelsberger Financial Advisory sold 175 Amgen shares in Q3 2025, an estimated $48.8K.
  • Livelsberger Financial Advisory first reported a position in Amgen in Q4 2023 and held it in 3 quarters.
  • Livelsberger Financial Advisory's Amgen position peaked at $56.3K in Q3 2024.
  • 2,823 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on Livelsberger Financial Advisory's 13F filing for Q3 2025, filed 14 Oct 2025.